Jaguar Health's Wholly Owned Subsidiary, Napo Pharmaceuticals, Inc., Commits to Support Study Evaluating the Effect of Crofelemer on Patients With Chronic Idiopathic Diarrhea
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.